BC

BioPharma Credit

North America, New York, United States, New York

Description

BioPharma Credit provides investors with an opportunity to gain exposure to the fast growing life sciences industry.

Investor Profile

BioPharma Credit has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Debt, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United States, Canada.
  • Strong thematic focus on Biotechnology, Biopharma, Medical.

Stage Focus

  • Post Ipo Debt (75%)
  • Pre Seed (25%)

Country Focus

  • United States (75%)
  • Canada (25%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Medical
  • Medical Device
  • Life Science
  • Health Care
  • Artificial Intelligence (Ai)
  • Dairy
  • Hospital
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioPharma Credit frequently co-invest with?

PA
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by BioPharma Credit?

Bioeureka

Montréal, Quebec, Canada

AI-powered image recognition technology for rapid pathogen identification.

Artificial Intelligence (AI)BiopharmaBiotechnologyDairyHospitalMedicalMedical DeviceSoftware
Pre SeedMay 10, 2024
Amount Raised: $1,096,772
Tarsus Pharmaceuticals

Irvine, California, United States

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.

BiopharmaBiotechnologyLife Science
Post Ipo DebtApr 19, 2024
Amount Raised: $75,000,000
BioDelivery Sciences

Raleigh, North Carolina, United States

BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Post Ipo DebtMay 28, 2019
Amount Raised: $60,000,000
NovoCure

Jersey, Arkansas, United States

An Oncology Company Pioneering a Novel Therapy for Solid Tumors

BiotechnologyHealth CareMedical DeviceOncology
Post Ipo DebtFeb 7, 2018
Amount Raised: $150,000,000